SCHEMBL30186397

SCHEMBL30186397

C=C(C(=O)Nc1nc(-c2cccnn2)cs1)c1ccc(O)c(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RRM1 P23921 2/20 0.50
RRM2B Q7LG56 2/20 0.50
ADORA3 P0DMS8 8/20 0.41
KDM4A O75164 2/20 0.41
KDM4B O94953 2/20 0.41
KDM5B Q9UGL1 2/20 0.41
MRE11 P49959 3/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
MCL1 Q07820 1/20 0.41
GRM1 Q13255 1/20 0.40
TYR P14679 1/20 0.39
KDM5C P41229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21484881 0.76 EGFR (0.53) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL30186382 0.72 RRM1 (0.53) RRM1RRM2BKDM4EMAPTMEN1
SCHEMBL30186374 0.71 RRM1 (0.49) RRM1RRM2BKDM4EMAPTMEN1
SCHEMBL28510115 0.70 MAPT (0.57) RRM1RRM2BMAPTMEN1ALDH1A1
SCHEMBL21484761 0.68 ABL1 (0.57) ADORA3KDM4AKDM4BKDM5BKDM4E
SCHEMBL10036571 0.67 RRM1 (1.00) RRM1RRM2BKDM4EMAPTMEN1
SCHEMBL11137540 0.66 RRM1 (0.70) RRM1RRM2BMRE11KDM4EMAPT
SCHEMBL21505929 0.65 RRM1 (0.57) RRM1RRM2BADORA3MRE11MAPT
SCHEMBL21505930 0.65 RRM1 (0.57) RRM1RRM2BADORA3MRE11MAPT
SCHEMBL30186439 0.65 RRM1 (0.57) RRM1RRM2BADORA3MRE11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases MASARYKOVA UNIVERZITA (CZ) 2023-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases RNASEH1, DNASE1, FEN1 RRM1 121/4885RRM2B 17/4885ADORA3 1009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.